FDAFDA · Food and drugs·Recall number D-0131-2020
Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30
Published October 16, 2019 · Recall initiated: September 6, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
GMP Deviation: lot not intended for commercial distribution.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- MATZIM LA
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.
- Lot
- Lot # 1344864A, exp. date 10/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.